Sudarshan Pharma Industries IPO

Sudarshan Pharma Industries IPO will open for subscription from 09 March 2023. the company aims for an issue size of ₹50.10 Cr through this IPO.

About Company

Incorporated in 2008, Mumbai-based Sudarshan Pharma Industries (SPIL) has a contract manufacturing facility to source and supply generic formulations. It is also engaged in import & export activities, and supply of specialty chemicals, API (Active Pharmaceutical Ingredients), and Intermediates. Based on clients’ specifications and requirements, they outsource the manufacturing facility from suppliers in India and abroad.

The generic products supplied by the company have wide applications in the paint, food, pharma, and adhesive industries. The company is involved in contract manufacturing, supplying, and outsourcing medicines and pharma formulation to hospitals, NGOs, government, and healthcare institutes. SPIL has 100 pharma formulations supplied under the brand name in the form of tablets, capsules, dry powder, dry injections powder, liquids, injections & dry injections.

The company has its own sales force and distribution network in 5 states for ethical marketing of pharmaceutical formulations & products under the brand name in Indian and international markets. It also offers formulation development and QC services and provides customized solutions. The company has exported to countries like Saudi Arabia, Qatar, Uzbekistan, Bangladesh, Ghana, Georgia, Taiwan, Sultanate of Oman, (Muscat) Dubai, (UAE) & UK.

Basic details about the company

Full nameSudarshan Pharma Industries Ltd
IndustryPharmaceuticals & Drugs
Company Website

The objective of the Issue

  • For Working Capital Requirements
  • General Corporate Purposes.

IPO Timetable

IPO Opening date09 March 2023
IPO Closing14 March 2023
Basis of Allotment17 March 2023
Initiation Refund20 March 2023
Credit to Demat Account21 March 2023
Listing Date22 March 2023

IPO details

Issue typeBook Built Issue IPO
IPO issue size₹50.10 Cr – 6,862,400 shares
Fresh Issue₹50.10 Cr – 6,862,400 shares
Offer for saleNil
Face value₹10 per share
Price Band₹71 to ₹73 per share
Lot size1600 Shares
Retail Allocation35% of the Net Issue
Listing ExchangeBSE SME

IPO Lot Size

Retail (Min)11600₹116,800
Retail (Max)11600₹116,800
HNI (Min)23,200₹233,600

Reservation Details

QIB Shares Offered50%
NII (HNI) Shares Offered15%
Retail Shares Offered35%

Financial Performance

 FY 2020FY 2021FY 2022Q1 FY 2023
Net income1.282.675.302.25
(Amount in ₹ Crors)

Valuations & Margins

FY 2020FY 2021FY 2022
PE ratio20.94 – 21.53
RONW (%)6.4311.8517.63
ROCE (%)22.6930.3435.29
EBITDA (%)3.233.903.20

Company Promoters

  • Mr. Hemal Vasantrai Mehta
  • Mr. Sachin Vasantrai Mehta

Promoter Holding

Pre Issue Share Holding80.28%
Post Issue Share Holding

Lead Manager(s)

  • Gretex Corporate Services Pvt Ltd

IPO Registrar

Selenium Tower – B, Plot 31 & 32, Gachibowli,
Financial District, Nanakramguda, Serilingampally,
Hyderabad – 500 032, Telangana
Telephone: +91 40 6716 2222

Contact Details

301,3rd Floor, Aura Biplex,
Above Kalyan Jewellers S. V. Road,
Borivali (West) Mumbai City Maharashtra 400092
Phone: 022- 022- 42221111

Allotment Status

Sudarshan Pharma IPO allotment status will be available on the KFin Tech website. Click on this link to get allotment status.

Final thoughts

Sudarshan Pharma Industries IPO is going to hit Dalal street soon. applying for an IPO is purely a personal choice. study well about the company and do subscribe if you are feeling good about the company. I hope this post will give you enough details to make a fundamental study of the company. learn well and make wise decisions.

Happy Investing

Leave a Comment

Your email address will not be published. Required fields are marked *